111, Inc. Sponsored ADR (NASDAQ:YI – Get Free Report) Director Jian David Sun sold 111,100 shares of the firm’s stock in a transaction on Thursday, June 11th. The stock was sold at an average price of $0.23, for a total value of $25,553.00. Following the completion of the transaction, the director owned 472,011 shares of the company’s stock, valued at $108,562.53. This trade represents a 19.05% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Jian David Sun also recently made the following trade(s):
- On Wednesday, June 10th, Jian David Sun sold 115,440 shares of 111 stock. The stock was sold at an average price of $0.22, for a total value of $25,396.80.
- On Tuesday, June 9th, Jian David Sun sold 12,000 shares of 111 stock. The stock was sold at an average price of $0.23, for a total value of $2,760.00.
- On Wednesday, May 27th, Jian David Sun sold 70,440 shares of 111 stock. The stock was sold at an average price of $0.25, for a total value of $17,610.00.
- On Tuesday, May 26th, Jian David Sun sold 29,280 shares of 111 stock. The stock was sold at an average price of $0.27, for a total value of $7,905.60.
111 Stock Performance
Shares of YI opened at $4.89 on Friday. The business’s 50-day moving average is $5.92 and its two-hundred day moving average is $5.64. The company has a market capitalization of $42.96 million, a P/E ratio of -3.49 and a beta of 0.60. 111, Inc. Sponsored ADR has a fifty-two week low of $2.48 and a fifty-two week high of $11.17.
Wall Street Analysts Forecast Growth
View Our Latest Stock Report on YI
About 111
111, Inc (NASDAQ: YI) is a leading online pharmacy e-commerce platform in China, operating under the brand 111.com. The company provides consumers with a comprehensive selection of pharmaceutical and healthcare products through its proprietary digital channels, including a website and mobile applications. By integrating online ordering, prescription management, and direct-to-consumer delivery, 111, Inc aims to streamline the purchase of medicines and health-related goods for customers nationwide.
111, Inc’s product portfolio encompasses prescription and over-the-counter drugs, nutritional supplements, vitamins, maternal and child care items, personal care products, and beauty goods.
See Also
- Five stocks we like better than 111
- Time to Sell? 3 Winners With Fading Technical Momentum
- Why These 2 Hotel Stocks Are Beating Travel Peers
- This Energy Stock Has Quietly Soared 130% in a Year
- 3 ‘Boring’ Dividend Stocks With Tasty Technical Setups
Receive News & Ratings for 111 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 111 and related companies with MarketBeat.com's FREE daily email newsletter.
